Patents by Inventor David M. Weinreich

David M. Weinreich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Predictive biomarker of survival in the treatment of renal cell carcinoma
    Patent number: 9151761
    Abstract: Methods and compositions are disclosed for predicting and treating the clinical benefit to a human renal cell carcinoma patient prior to their treatment with a VEGFR inhibitor and an Ang2 inhibitor.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: October 6, 2015
    Assignee: Amgen Inc.
    Inventors: Abraham Antonio Anderson, David M. Weinreich
  • PREDICTIVE BIOMARKER OF SURVIVAL IN THE TREATMENT OF RENAL CELL CARCINOMA
    Publication number: 20140348824
    Abstract: Methods and compositions are disclosed for predicting and treating the clinical benefit to a human renal cell carcinoma patient prior to their treatment with a VEGFR inhibitor and an Ang2 inhibitor.
    Type: Application
    Filed: June 28, 2012
    Publication date: November 27, 2014
    Applicant: AMGEN INC.
    Inventors: Abraham Antonio Anderson, David M. Weinreich
  • TREATMENT OF OVARIAN CANCER USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE
    Publication number: 20120183546
    Abstract: Methods and compositions for treating ovarian cancer in a patient comprising administering a therapeutically effective amount of an Angiopoictin-2 inhibitor in combination with a taxane.
    Type: Application
    Filed: September 23, 2010
    Publication date: July 19, 2012
    Applicant: AMGEN INC.
    Inventor: David M. Weinreich